$CARA News Article - Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA?? (CR845/difelikefalin) for Pruritus in Patients with Primary Biliary Cholangitis (PBC) https://marketwirenews.com/news-releases/cara...16354.html
(0)
(0)
Cara Therapeutics, Inc. (CARA) Stock Research Links